Abstract LB-100: Discovery of HM61713 as an orally available and mutant EGFR selective inhibitor

Article Details

Citation

Kwang O-K, Cha MY, Kim M, Song JY, Lee J-H, Kim YH, Lee Y-M, Suh KH, Son J.

Abstract LB-100: Discovery of HM61713 as an orally available and mutant EGFR selective inhibitor

Cancer Res. 2014 October;74(19 Suppl.):Abstract nr LB-100.

PubMed ID
Not Available
Abstract

Not Available

DrugBank Data that Cites this Article

Drugs
Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
OlmutinibEpidermal growth factor receptorProteinHumans
Yes
Inhibitor
Details